These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14683529)

  • 41. Transplantation of mesenchymal cells improves peripheral limb ischemia in diabetic rats.
    Madonna R; Delli Pizzi S; Tartaro A; De Caterina R
    Mol Biotechnol; 2014 May; 56(5):438-48. PubMed ID: 24504870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularization.
    Schgoer W; Theurl M; Albrecht-Schgoer K; Jonach V; Koller B; Lener D; Franz WM; Kirchmair R
    PLoS One; 2013; 8(9):e74029. PubMed ID: 24086307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PKCδ impaired vessel formation and angiogenic factor expression in diabetic ischemic limbs.
    Lizotte F; Paré M; Denhez B; Leitges M; Guay A; Geraldes P
    Diabetes; 2013 Aug; 62(8):2948-57. PubMed ID: 23557702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ephrin-B2-activated peripheral blood mononuclear cells from diabetic patients restore diabetes-induced impairment of postischemic neovascularization.
    Broquères-You D; Leré-Déan C; Merkulova-Rainon T; Mantsounga CS; Allanic D; Hainaud P; Contrères JO; Wang Y; Vilar J; Virally M; Mourad JJ; Guillausseau PJ; Silvestre JS; Lévy BI
    Diabetes; 2012 Oct; 61(10):2621-32. PubMed ID: 22596048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imaging the effect of receptor for advanced glycation endproducts on angiogenic response to hindlimb ischemia in diabetes.
    Tekabe Y; Shen X; Luma J; Weisenberger D; Yan SF; Haubner R; Schmidt AM; Johnson L
    EJNMMI Res; 2011 Jun; 1(1):3. PubMed ID: 22214528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice.
    Cao L; Arany PR; Kim J; Rivera-Feliciano J; Wang YS; He Z; Rask-Madsen C; King GL; Mooney DJ
    Biomaterials; 2010 Dec; 31(34):9048-56. PubMed ID: 20800279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia.
    Rissanen TT; Rutanen J; Ylä-Herttuala S
    Adv Genet; 2004; 52():117-64. PubMed ID: 15522734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model.
    Roguin A; Nitecki S; Rubinstein I; Nevo E; Avivi A; Levy NS; Abassi ZA; Sabo E; Lache O; Frank M; Hoffman A; Levy AP
    Cardiovasc Diabetol; 2003 Dec; 2():18. PubMed ID: 14683529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
    Zheng ZH; Xu L; Fan XH
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):142-5. PubMed ID: 15065417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restoration of coronary collateral growth in the Zucker obese rat: impact of VEGF and ecSOD.
    Hattan N; Chilian WM; Park F; Rocic P
    Basic Res Cardiol; 2007 May; 102(3):217-23. PubMed ID: 17323199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF.
    Roguin A; Avivi A; Nitecki S; Rubinstein I; Levy NS; Abassi ZA; Resnick MB; Lache O; Melamed-Frank M; Joel A; Hoffman A; Nevo E; Levy AP
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4644-8. PubMed ID: 12672967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.
    Tepper OM; Galiano RD; Capla JM; Kalka C; Gagne PJ; Jacobowitz GR; Levine JP; Gurtner GC
    Circulation; 2002 Nov; 106(22):2781-6. PubMed ID: 12451003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.
    Simons M; Annex BH; Laham RJ; Kleiman N; Henry T; Dauerman H; Udelson JE; Gervino EV; Pike M; Whitehouse MJ; Moon T; Chronos NA
    Circulation; 2002 Feb; 105(7):788-93. PubMed ID: 11854116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
    Taniyama Y; Morishita R; Hiraoka K; Aoki M; Nakagami H; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Circulation; 2001 Nov; 104(19):2344-50. PubMed ID: 11696476
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.